FIELD: pharmaceutical industry.
SUBSTANCE: method for obtaining a platelet releasate containing growth factors, the use of the obtained releasate and a composition for regenerative medicine. Method for obtaining a platelet release containing growth factors from a liquid concentrate of mammalian platelets, with the following successive steps: reduction of the content of pathogenic microorganisms in the platelet concentrate by destroying non-enveloped viruses; activation of the platelet concentrate to initiate the release of growth factors and alpha granules by platelets; isolation of fibrinogen-depleted liquid platelet release, treating the fibrinogen-depleted liquid platelet release to reduce pathogen concentration and destroy enveloped viruses; sterilizing filtration with the release of a filtered liquid containing growth factors, followed by division into portions with the same content of platelets 2×105-2×207 per cm3. Composition for regenerative medicine. The use of platelet releasate in regenerative medicine. Use of platelet releasate in cell culture media.
EFFECT: obtaining a therapeutic agent for enhancing the proliferation of cells of multiple lines in regenerative medicine and in the treatment of non-healing wounds and resistant ulcers, as well as in cell culture media.
20 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
INTEGRATED HUMAN PLATELET LYSATE, A METHOD OF PRODUCING INTEGRATED HUMAN PLATELET LYSATE AND THE USE OF INTEGRATED HUMAN PLATELET LYSATE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | 2018 |
|
RU2802440C2 |
METHOD OF PRODUCING FIBRINOGEN USING STRONG ANION EXCHANGE RESIN AND FIBRINOGEN-CONTAINING PRODUCT | 2011 |
|
RU2603103C2 |
METHOD FOR CLEANING FIBRINOGEN, FIBRINOGEN PRODUCT AND MEANS FOR CLEANING OR PRODUCING FIBRINOGEN PRODUCT | 2013 |
|
RU2663792C2 |
METHOD FOR PRODUCING HIGHLY VIRUS-SAFETY COMPONENTS FOR PREPARING FIBRIN GLUE FROM HUMAN PLASMA BLOOD POOL | 1998 |
|
RU2236237C2 |
METHOD OF PREPARING BIOLOGICAL ADHESIVE MADE OF CONCENTRATED COAGULATING FACTORS BY SALTING OUT | 1994 |
|
RU2130946C1 |
METHOD OF OBTAINING SAFE IN VIRUS RESPECT BIOLOGICAL FLOWING MEDIA | 2005 |
|
RU2411959C2 |
METHOD OF OBTAINING FIBRINOGEN CONCENTRATE | 2013 |
|
RU2556804C2 |
SERUM FRACTION OF THROMBOCYTE-ENRICHED FIBRIN | 2014 |
|
RU2711330C2 |
METHOD FOR PRODUCING A CULTURE GROWTH SUPPLEMENT BASED ON HUMAN PLATELET LYSATE | 2017 |
|
RU2664478C2 |
METHOD, TEST TUBE AND DEVICE FOR MAKING OF COMPOSITIONS FOR WOUND HEALING | 2011 |
|
RU2614722C2 |
Authors
Dates
2023-05-12—Published
2017-11-20—Filed